Home » Topics » BioWorld Science

BioWorld Science
RSS

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent GLP-1 receptor agonists

Oct. 25, 2021

PKMYT1 inhibitors discovered at Repare Therapeutics

Oct. 25, 2021

Monash University divulges antibiotic peptide-drug conjugates

Oct. 25, 2021

Bayer and collaborators describe new EGFR inhibitors

Oct. 25, 2021

CHD8 haploinsufficiency leads to seizure phenotype

Oct. 25, 2021

Biallelic variants in the KARS1 gene tied to neurodevelopmental disorders and hearing loss

Oct. 25, 2021

Understanding DNA repair mechanisms allows for crisper CRISPR genome editing

Oct. 25, 2021

Regeneron ADC REGN3124-PBD prolongs survival in mice with intracranial glioblastoma tumors

Oct. 22, 2021

Splice variant in DEGS1 leads to hypomyelinating leukodystrophy-like phenotype

Oct. 22, 2021

Atreca and Gates MRI enter licensing agreement on MAM-01 for malaria

Oct. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...